The vaccine maker said Wednesday that revenue from its coronavirus preventive shots jumped to $5.92 billion from $1.73 billion in last year’s quarter, when the vaccines were debuting in most markets.
from Section Page News - Modern Healthcare https://ift.tt/dw6WZou
